GXMC
LOXO

Global X Management Company’s Loxo Oncology, Inc LOXO Stock Holding History

Global X Management Company’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$52K Buy
+300
New +$45.1K ﹤0.01% 1080

Other funds holding LOXO

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Global X Management Company's LOXO Position: Q2 2018 in Review

Global X Management Company opened a new position in Loxo Oncology, Inc (LOXO) in Q2 2018: 300 shares worth $52K. The stake represents ﹤0.01% of the portfolio and ranks #1080 among its holdings.

213 funds tracked by Wall St. Rank hold LOXO as of Q2 2018.

  • Global X Management Company held 300 shares of Loxo Oncology, Inc worth $52K as of Q2 2018.
  • Loxo Oncology, Inc was a new Global X Management Company position in Q2 2018.
  • Loxo Oncology, Inc made up ﹤0.01% of Global X Management Company's portfolio in Q2 2018, its #1080 holding.
  • 213 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.